https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
140
 
downloads
6
CITE
How to cite this poster:
Smith T, Pierce M, Wilks K et al. Long term safety of the sumatriptan iontophoretic transdermal patch, NP101, for acute migraine: a 12 month, repeat use, open label study. F1000Posters 2012, 3:668 (poster)

Long term safety of the sumatriptan iontophoretic transdermal patch, NP101, for acute migraine: a 12 month, repeat use, open label study

Timothy Smith, Mark Pierce1, Kerri Wilks, Carol O'Neill, Steven Silberstein
Published 20 Jun 2012
Author Affiliations
  • Metrics
  • 140 Views
  • 6 Downloads
Browse by related subjects
Published 20 Jun 2012

Long term safety of the sumatriptan iontophoretic transdermal patch, NP101, for acute migraine: a 12 month, repeat use, open label study

[version 1; not peer reviewed]

Timothy Smith, Mark Pierce1, Kerri Wilks, Carol O'Neill, Steven Silberstein
Author Affiliations
1 Medical Affairs, NuPathe Inc, USA
Presented at
54th American Headache Society Annual Meeting 2012
Abstract
Competing Interests

Authors Timothy Smith, Kerri Wilks and Steven Silberstein served as clinical investigators and scientific advisers for NuPathe Inc. Corresponding author Mark Pierce and author Carol O' Neill are paid employees of NuPathe Inc.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.